Michel Milinkovitch Overview
- Investor Type
-
Angel
- Investments
-
1
- Exits
-
1
Michel Milinkovitch General Information
Description
Mr. Michel Milinkovitch is an Angel Investor. Michel Milinkovitch has been a Professor in the Department of Genetics and Evolution of the Faculty of Sciences at the University of Geneva since 2008 and President of the Biology Section since 2019. He has also been a member of the Institute of Genetics and Genomics of Geneva (iGE3) since its foundation (2011) and a group leader at the Swiss Institute of Bioinformatics (SIB) since 2014. In what he calls his "previous life", as an evolutionary geneticist, he developed concepts, analytical tools and algorithms for molecular sequence alignments, the reconstruction of the phylogenetic tree of life and the genetics of natural populations (notably Galapagos tortoises).
Business Details
Primary Investor Type
Michel Milinkovitch Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Delphi Genetics | 10-Mar-2015 | Biotechnology | Generating Revenue |
Michel Milinkovitch Exits (1)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Delphi Genetics | 25-Feb-2021 |
Michel Milinkovitch Investments by Industry, Year, and Region
Michel Milinkovitch Team (1)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Michel Milinkovitch | Angel Investor |
Michel Milinkovitch FAQs
-
Who is Michel Milinkovitch?
Michel Milinkovitch is an angel Investor who has made 1 investment.
-
What kind of investor is Michel Milinkovitch?
Michel Milinkovitch is an angel investor.
-
What does Michel Milinkovitch do?
As an angel investor, Michel Milinkovitch invests personal money into promising companies, typically in exchange for equity.
-
What has Michel Milinkovitch invested in?
Michel Milinkovitch has invested in Delphi Genetics within the Biotechnology industry.
-
What has Michel Milinkovitch invested in recently?
Michel Milinkovitch's latest investment was on 10-Mar-2015 in Delphi Genetics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »